Cardio Diagnostics Holdings, Inc. Business Combination, Consideration Transferred, Other
Cardio Diagnostics Holdings, Inc. (CDIO) reported Business Combination, Consideration Transferred, Other of $5.00 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferredOther1 · last filed 2022-08-10
- Cardio Diagnostics Holdings, Inc. business combination, consideration transferred, other for the quarter ending 2022-06-30 was $0.00.
- Cardio Diagnostics Holdings, Inc. business combination, consideration transferred, other for the quarter ending 2022-03-31 was $5.00M.
| Period end | Business Combination, Consideration Transferred, Other 3 month | Business Combination, Consideration Transferred, Other 6 month | Business Combination, Consideration Transferred, Other 7 month |
|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $5.00M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $5.00M 10-Q · filed 2022-05-12 | ||
| 2021-12-31 | $5.00M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |